Is Broadcom Stock Overvalued?
The semiconductor company Broadcom Inc. (NASDAQ:AVGO) is having a stellar…
Sell
39
TAK Quote, Financials, Valuation and Earnings
Last price:
$12.96
Seasonality move
:
-0.07%
Day range:
$12.95 - $13.13
52-week range:
$12.58 - $15.08
Dividend yield:
4.78%
P/E ratio:
21.43x
P/S ratio:
1.37x
P/B ratio:
0.85x
Volume:
2.3M
Avg. volume:
1.7M
1-year change:
-12.97%
Market cap:
$41.1B
Revenue:
$29.5B
EPS (TTM):
$0.60
Earnings Data
Next earnings date for TAK
Jan 31
2025
Most recent earnings per share
$0.19
Beat by $0.19
(Oct 31/2024)
Consensus Estimate
--
(Oct 31/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TAK Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q1 | $6.9B | -- | -- | -- | -- |
| 01/31/2025 | Q4 | $7.5B | -- | -- | -- | -- |
| 10/31/2024 | Q3 | $7.2B | $7.9B | $0.19 | -- | -- |
| 07/31/2024 | Q2 | $6.8B | $7.7B | $0.19 | -- | -- |
| 05/09/2024 | Q1 | $5.8B | $7.1B | -$0.01 | -- | -- |
| 02/01/2024 | Q4 | $6.8B | $7.5B | $0.23 | -- | -- |
| 10/26/2023 | Q3 | -- | -- | -$0.11 | -- | -- |
| 07/27/2023 | Q2 | -- | -- | $0.21 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | $0.07 | -- | -- |
| 02/02/2023 | Q4 | -- | -- | $0.27 | -- | -- |
| 10/27/2022 | Q3 | -- | -- | $0.14 | -- | -- |
| 07/28/2022 | Q2 | -- | -- | $0.26 | -- | -- |
| 05/11/2022 | Q1 | -- | -- | -$0.03 | -- | -- |
| 02/03/2022 | Q4 | -- | -- | $0.16 | -- | -- |
| 10/28/2021 | Q3 | -- | -- | $0.13 | -- | -- |
| 07/30/2021 | Q2 | -- | -- | $0.40 | -- | -- |
| 05/11/2021 | Q1 | -- | -- | $0.59 | -- | -- |
| 02/04/2021 | Q4 | -- | -- | $0.28 | -- | -- |
| 10/29/2020 | Q3 | -- | -- | $0.01 | -- | -- |
| 07/31/2020 | Q2 | -- | -- | $0.24 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | $0.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.10 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | $0.16 | -- | -- |
Takeda Pharmaceutical Earnings Questions
-
How Much did Takeda Pharmaceutical Generate in Revenue Last Quarter?
Takeda Pharmaceutical reported $7.9B worth of top line sales in its most recent quarter.
-
Did Takeda Pharmaceutical Beat Earnings Last Quarter?
Takeda Pharmaceutical announced earnings per share of $0.19 which represents a beat of analyst forecast a -- per share.
-
Is Takeda Pharmaceutical Profitable?
Takeda Pharmaceutical reported $5.3B that represents $1.63 per share over the last quarter.
-
What is the Analyst Consensus for Takeda Pharmaceutical EPS Next Year?
Takeda Pharmaceutical's earnings are forecast to grow from $0.32 per share to -- per share next year representing an increase of --.
-
When is Takeda Pharmaceutical's Earnings Date?
Takeda Pharmaceutical's next earnings date is January 31, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
4 Top Dividend Stocks to Buy Now
If you’re looking for steady income, dividend stocks are a…
Will Uber Stock Recover?
Shares of Uber Technologies (NYSE:UBER) have had a rough few…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 39x
Sell
47
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 114x
Sell
39
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
87
CEG alert for Jan 11
Constellation Energy [CEG] is up 25.15% over the past day.
Sell
1
MCY alert for Jan 11
Mercury General [MCY] is down 19.87% over the past day.
Buy
84
ATZAF alert for Jan 11
Aritzia [ATZAF] is up 17.63% over the past day.
